In a 2-year double-blind study, 35% of patients taking an acetylcholinesterase inhibitor to slow cognitive decline due to AD had a recurrence of major depressive episodes vs. 19% of those on a placebo (Reynolds et al., 2011). This evidence concerns the gene ACHE and Alzheimer disease.